Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007–2013)
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
Brundage, M., Blazeby, J., Revicki, D., Bass, B., de Vet, H., Duffy, H., Efficace, F., King, M., Lam, C. L. K., Moher, D., et al. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0252-1 · Cited by 207 · cited 1×
“The International Society for Quality of Life Research has developed reporting standards for PROs in randomized controlled trials [28].”
Method
Cited by
Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018) · Patient Related Outcome Measures · doi:10.2147/prom.s156279 · Cited by 659
“Consecutive reviews of ClinicalTrials.gov in 2004–2007 5 and 2007–2013 6 determined that use of PRO endpoints had increased from 14% to 27% of trials over that period.”
Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30790-9 · Cited by 323
Chemaly, N., Kuchenbuch, M., Teng, T., Marie, E., D'Onofrio, G., Lo Barco, T., Brambilla, I., Flege, S., Hallet, A., & Nabbout, R. (2024) · Epilepsia Open · doi:10.1002/epi4.12557 · Cited by 20
“The 26– 28 The development of specific PROs for DS may seem anecdotic because there are generic PROs, such as the health-related quality of life.”
Background
Metadata
- Authors
- Vodicka, E., Kim, K., Devine, E. B., Gnanasakthy, A., Scoggins, J. F., & Patrick, D. L.
- Venue
- Contemporary Clinical Trials
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 43
- Pages
- 1-9
- ISSN
- 1551-7144 (ISSN-L)
- OpenAlex
- W1985794687
- Cited by
- 211
- References
- 1
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.